Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
 
 
Email
csiwl@nus.edu.sg
 
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Type:  Article
Department:  CANCER SCIENCE INSTITUTE OF SINGAPORE

Results 41-56 of 56 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
412015Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesWong, Andrea; Soo, Ross A.; Tan, Daniel; Lee, Soo Chin ; Lim, Joline S J; Marban, P.C.; Kong, Li Ren ; Lee, Youngjoo; Wang, Lingzhi ; Thuya, Win Lwin ; Soong, R.; Yee, M.Q.; Chin, T.M.; Cordero, Maricel Tiemsim; Asuncion, Bernadette Reyna ; Pang, B.; Pervaiz, Shazib ; Hirpara, Jayshree L. ; Sinha, Arvind; Xu, W.W.; Yuasa, M.; Tsunoda, T.; Motoyama, M.; Yamauchi, T.; Goh, Boon Cher 
421-Aug-2003Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group studySoo, R.A. ; Lim, H.L.; Wang, L.Z. ; Lee, H.S.; Millward, M.J.; Tok, L.T.; Lee, S.C. ; Lehnert, M.; Goh, B.C.
432016Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerWong A.L.A. ; Sundar R.; Wang T.-T. ; Ng T.-C. ; Zhang B. ; Tan S.-H. ; Soh T.I.P.; Pang A.S.L.; Tan C.-S.; Ow S.G.W.; Wang L. ; Mogro J.; Ho J.; Jeyasekharan A.D. ; Huang Y.; Thng C.-H. ; Chan C.-W. ; Hartman M. ; Iau P.; Buhari S.A. ; Goh B.-C. ; Lee S.-C. 
442001Phenolic compounds of Chromolaena adorata protect cultured skin cells from oxidative damage: Implication for cutaneous wound healingPhan, T.-T.; Wang, L. ; See, P.; Grayer, R.J.; Chan, S.-Y. ; Lee, S.T.
451-Mar-2003Phenotyping CYP3A using midazolam in cancer and noncancer Asian patientsLee, H.S.; Goh, B.C.; Fan, L.; Khoo, Y.M.; Wang, L. ; Lim, R.; Ong, A.B.; Chua, C.
462019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
47Apr-2008PXR, CAR and HNF4α genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patientsHor, S.Y.; Lee, S.C. ; Wong, C.I.; Lim, Y.W.; Lim, R.C.; Wang, L.Z. ; Fan, L.; Guo, J.Y. ; Lee, H.S.; Goh, B.C.; Tan, T. 
48Mar-2013Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Thuya, W.-L. ; Toh, D.S.-L.; Lie, M.G.-L.; Lau, J.-Y.A.; Kong, L.-R.; Wan, S.-C.; Chua, K.-N.; Lee, E.J.-D.; Goh, B.-C.
4926-Feb-2003Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assayWang, L.Z. ; Ho, P.C. ; Lee, H.S.; Vaddi, H.K.; Chan, Y.W.; Yung, C.S. 
5015-Jul-2011Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Lim, M.Y.-X.; Chin, T.-M. ; Thuya, W.-L. ; Nye, P.-L.; Wong, A.; Chan, S.-Y. ; Goh, B.-C.; Ho, P.C. 
512009Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effectWang, L.-Z. ; Yong, W.-P. ; Soo, R.-A. ; Lee, S.-C. ; Soong, R. ; Lee, H.-S.; Goh, B.-C.
521-Sep-2021Resveratrol for cancer therapy: Challenges and future perspectivesRen, Boxu; Kwah, Marabeth Xin-Yi; Liu, Cuiliu; Ma, Zhaowu; Shanmugam, Muthu K. ; Ding, Lingwen ; Xiang, Xiaoqiang; Ho, Paul Chi-Lui ; Wang, Lingzhi ; Ong, Pei Shi ; Goh, Boon Cher 
532004Sensitive high-performance liquid chromatography/mass spectrometry method for determination of steviol in rat plasmaWang, L.Z. ; Goh, B.C.; Fan, L.; Lee, H.S.
54Feb-2011Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric methodWang, L.-Z. ; Lee, L.S.-U.; Thuya, W.-L. ; Soon, G.H.; Kong, L.-R.; Nye, P.-L.; Deoon Lee, E.J.; Flexner, C.; Goh, B.-C.
5529-Apr-2020Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationKong, Li Ren ; Ong, Richard Weijie; Tan, Tuan Zea ; Salleh, Nur Afiqah Binte Mohamed ; Thangavelu, Matan; Chan, Jane Vin; Koh, Lie Yong Judice; Periyasamy, Giridharan; Lau, Jieying Amelia ; Le, Thi Bich Uyen; Wang, Lingzhi ; Lee, Miyoung; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Chwee Ming ; Chng, Wee Joo ; Lane, David P ; Venkitaraman, Ashok ; Hung, Huynh The; Cheok, Chit Fang ; Goh, Boon Cher 
562015Validation of a rapid and sensitive LC-MS/ MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: Application to human pharmacokinetics studyWang Lingzhi ; Goh, Sokhwei; Wong, Andrea; Thuya, Win Lwin; Lau, Jie Ying Amelia ; Wan, Seowching ; Ho Chi Lui, Paul ; Goh, Booncher